• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER VASCULAR PLUG II; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER VASCULAR PLUG II; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION Back to Search Results
Model Number 9-AVP2-022
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Gastrointestinal Hemorrhage (4476); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/14/2025
Type of Reportable Event Death
Event or Problem Description
It was reported that on (b)(6) 2025, a 22mm amplatzer vascular plug ii was implanted in the patient for retrograde transvenous obliteration (parto).After the procedure, the patient passed away.
 
Additional Manufacturer Narrative
The device remains implanted in patient.The device will not be returned for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Additional Manufacturer Narrative
An event of gastrointestinal hemorrhage with a patient outcome of death was reported.A medical review was completed and concluded that the exact cause of death is unknown.Since the fatality occurred 10 days post implant and there is no report of any complications, most likely the death is related to underlying comorbidities of the patient.A returned device assessment could not be performed as the device remains implanted.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all defined manufacturing specifications.There were no complaints associated with any other devices from the lot.Based on the available information, the cause for the reported gastrointestinal hemorrhage with a patient outcome of death could not be confirmed.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.Codes removed: health effect-clinical code: 4582 no clinical signs, symptoms or conditions.
 
Event or Problem Description
It was reported that on (b)(6) 2025, a 22mm amplatzer vascular plug ii was implanted in the patient for retrograde transvenous obliteration (parto).The plug was successfully implanted.On (b)(6) 2025, the patient was reported passed away.The cause of death was gastrointestinal (gi) bleeding.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER VASCULAR PLUG II
Common Device Name
DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG# 2135147
5050 nathan ln n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key23378754
Report Number2135147-2025-06062
Device Sequence Number9202096
Product Code KRD
UDI-Device Identifier00811806010441
UDI-Public(01)00811806010441(17)300430(10)10871562
Combination Product (Y/N)N
Initial Reporter StatePR
Initial Reporter CountryUS
PMA/510(K) Number
K071699
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/04/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number9-AVP2-022
Device Catalogue Number9-AVP2-022
Device Lot Number10871562
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/29/2025
Supplement Date Received by Manufacturer11/28/2025
Initial Report FDA Received Date10/24/2025
Supplement Report FDA Received Date12/04/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured05/19/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Death;
Patient Age56 YR
Patient SexFemale
-
-